P53ABN

Clinical trials for P53ABN explained in plain language.

Never miss a new study

Get alerted when new P53ABN trials appear

Sign up with your email to follow new studies for P53ABN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug could keep aggressive uterine cancer at bay

Disease control Recruiting now

This study tests whether taking a daily pill called olaparib for one year after standard treatment can help prevent endometrial cancer from coming back. It is for people with a specific type of aggressive endometrial cancer (p53abn). About 554 participants will be randomly assign…

Matched conditions: P53ABN

Phase: PHASE3 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control

Last updated May 13, 2026 16:02 UTC

P53ABN

Get alerted when new P53ABN trials appear

New drug could keep aggressive uterine cancer at bay